Ifp Advisors, Inc Seagen Inc. Transaction History

Ifp Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	BUY	$0.0 - $228.9 $0 - $67,296	294 Added 26.06%	1,422 $0
Q3 2023 Oct 12, 2023	BUY	$191.51 - $216.16 $2,298 - $2,593	12 Added 1.08%	1,128 $239,000
Q2 2023 Aug 04, 2023	BUY	$187.64 - $206.25 $5,629 - $6,187	30 Added 2.76%	1,116 $214,000
Q1 2023 Apr 18, 2023	SELL	$127.59 - $203.08 $37,256 - $59,299	-292 Reduced 21.19%	1,086 $219,000
Q4 2022 Feb 07, 2023	SELL	$117.37 - $139.17 $3,990 - $4,731	-34 Reduced 2.41%	1,378 $280,000
Q3 2022 Nov 08, 2022	BUY	$135.27 - $180.11 $7,845 - $10,446	58 Added 4.28%	1,412 $300,000
Q2 2022 Sep 06, 2022	BUY	$108.81 - $179.33 $147,328 - $242,812	1,354 New	1,354 $289,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $147,328 - $242,812	-1,354 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$119.61 - $157.85 $128,700 - $169,846	1,076 Added 387.05%	1,354 $195,000
Q1 2022 Aug 08, 2022	BUY	$119.61 - $157.85 $30,141 - $39,778	252 Added 969.23%	278 $40,000
Q3 2021 Oct 06, 2021	SELL	$142.45 - $169.82 $142 - $169	-1 Reduced 3.7%	26 $5,000
Q2 2021 Jul 13, 2021	BUY	$135.08 - $161.1 $135 - $161	1 Added 3.85%	27 $4,000
Q1 2021 Apr 30, 2021	SELL	$137.51 - $190.8 $44,690 - $62,010	-325 Reduced 92.59%	26 $3,000
Q4 2020 Jan 25, 2021	BUY	$164.63 - $211.93 $57,785 - $74,387	351 New	351 $61,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.